Award
Eunice Kennedy Shriver National Institute of Child Health and Human Development 5R01HD116839-03
A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment
Recipient
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
Award Amount
$645,254.00
Ceiling
$645,254.00
Awarded
May 28, 2026
Identifier
5R01HD116839-03
The award supports research to develop a novel probiotic treatment to prevent and treat neurodevelopmental impairment caused by neonatal necrotizing enterocolitis (NEC) in premature infants, using a biofilm delivery system for Limosilactobacillus reuteri.
Description
This project aims to develop an FDA-approved probiotic formulation to prevent and treat NEC-induced neurodevelopmental impairment in premature infants, leveraging a novel biofilm delivery system of Limosilactobacillus reuteri.